The findings emphasized the substantial predictive efficacy of both Lp(a) (AUC 0.730 [95% CI 0.678–0.783]; p < 0.001) and Lp‐PLA2 (AUC 0.716 [95% CI 0.659–0.773]; p < 0.001) for anticipating stroke recurrence in AIS patients. This evidence concerns the gene PLA2G7 and Stroke.